ABPWW
Abpro Holdings, Inc.
OTC Biological Products, (No Diagnostic Substances)
Emerging growth company

Key Financials

Revenue
$183000
↑ 50.0%
Net Income
$2.8M
↑ 218.1%
Operating Income
$-8452000
↑ 14.8%
EPS (Diluted)
$-1.30
↓ 75.7%
Total Liabilities
$19.6M
↑ 5.5%
Shareholders' Equity
$-8831000.00
↑ 43.0%
Total Assets
$1.1M
↓ 77.2%
Cash & Equivalents
$2.9M
↑ 977.3%

Recent SEC Filings

Form Type Filed Date Link
8-K 6/4/2026 View on SEC
10-Q 5/20/2026 View on SEC
NT 10-Q 5/15/2026 View on SEC
10-K/A 5/1/2026 View on SEC
10-K 4/15/2026 View on SEC
NT 10-K 3/31/2026 View on SEC
8-K 2/20/2026 View on SEC
8-K 2/11/2026 View on SEC
SCHEDULE 13G 2/9/2026 View on SEC
8-K 2/3/2026 View on SEC

Company Information

Field Value
Ticker ABPWW
Company Name Abpro Holdings, Inc.
CIK 1893219
Sector Biological Products, (No Diagnostic Substances)
Industry
Emerging growth company
Exchange OTC
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 248-890-7200